Find News

Filter articles

Showing 3141 to 3150 of 3438 results

Indian Patent Office rejects anti-cancer drug patent


The Indian Patent Office has rejected a patent application for an anti-cancer drug for the second time, paving the way for generic versions to potentially enter the market.

Teva reaches settlement in ProAir patent case


Teva has reached a settlement in its patent battle with two pharmaceutical companies, ending all litigation over its ProAir HFA (albuterol sulfate) inhalation aerosol.

Victory for Bayer as CJEU grants safeners extra protection


Europe’s highest court has said that products used by agrochemical companies to help maintain plants can be given extended patent protection.

Holland & Knight nabs life sciences litigator


Holland & Knight LLP has expanded its IP practice group with the hire of patent litigator Howard Suh as partner.

Canada and Australia in new stem cell partnership

Australia, Canada16-06-2014

Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries.

Merck to acquire Idenix for $3.85bn


Drug giant Merck is to acquire biopharmaceutical company Idenix for $24.50 per share, valuing the purchase at around $3.85 billion.

Actavis and Zydus settle Asacol patent dispute

Ireland, US10-06-2014

Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.

Dechert hires life sciences partner in Frankfurt


Law firm Dechert LLP has appointed Rüdiger Herrmann as a partner in its Frankfurt office.

Ferumoxytol patent extended by USPTO


AMAG Pharmaceuticals, Inc. has had a US patent covering ferumoxytol extended.

Kite Pharma enters into licensing agreement with NIH


Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer.

Showing 3141 to 3150 of 3438 results